Does URAPIDIL Cause Hepatic cytolysis? 59 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 59 reports of Hepatic cytolysis have been filed in association with URAPIDIL. This represents 3.5% of all adverse event reports for URAPIDIL.
59
Reports of Hepatic cytolysis with URAPIDIL
3.5%
of all URAPIDIL reports
1
Deaths
18
Hospitalizations
How Dangerous Is Hepatic cytolysis From URAPIDIL?
Of the 59 reports, 1 (1.7%) resulted in death, 18 (30.5%) required hospitalization.
Is Hepatic cytolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for URAPIDIL. However, 59 reports have been filed with the FAERS database.
What Other Side Effects Does URAPIDIL Cause?
Acute kidney injury (187)
Fall (150)
Hypotension (148)
Hyperkalaemia (78)
Drug ineffective (77)
Hyponatraemia (69)
Bradycardia (66)
Toxic epidermal necrolysis (63)
Condition aggravated (61)
Dizziness (60)
What Other Drugs Cause Hepatic cytolysis?
ACETAMINOPHEN (1,469)
ATORVASTATIN (681)
PEMBROLIZUMAB (601)
CARBOPLATIN (577)
METHOTREXATE (468)
SULFAMETHOXAZOLE\TRIMETHOPRIM (356)
PACLITAXEL (324)
ENOXAPARIN (307)
AMOXICILLIN (273)
VALACYCLOVIR (261)
Which URAPIDIL Alternatives Have Lower Hepatic cytolysis Risk?
URAPIDIL vs UREA
URAPIDIL vs URIDINE TRIACETATE
URAPIDIL vs UROFOLLITROPIN
URAPIDIL vs URSODIOL
URAPIDIL vs USTEKINUMAB